Skip to main content

Table 2 Antiestrogenic and antiproliferative activity of compound 9

From: Estrogen alpha receptor antagonists for the treatment of breast cancer: a review

Compound No.

(IC50 = µM)

Antiestrogenic activity

Antiproliferative activity (MCF-7)

9

0.050

0.022

Fulvestrant

0.003

0.004